Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexiline in heart failure with preserved ejection fraction
ISRCTN25678870Phase 3Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Mar 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) comparing Perhexiline with Placebo (2 arms). Primary endpoint: Peak oxygen consumption. Started Mar 2009; status: completed.
02
Drugs
perhexiline
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on ISRCTN25678870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN25678870.